On July 14, physician and Space Force colonel Anil Menon lifted off from the ancient steppe of Kazakhstan aboard a Russian Soyuz capsule, bound for eight months on the International Space Station. His mission is less about the journey itself than about what comes after — the Moon, Mars, and the profound medical unknowns that await human beings who venture that far from home. Born in Minneapolis to immigrant parents who crossed continents to build a life, Menon now crosses into orbit carrying questions whose answers may determine whether humanity can sustain itself beyond Earth's embrace.
Indian-origin NASA astronaut Anil Menon launches to ISS for 8-month scientific mission
keeping astronauts alive when they get there
Mark
So Menon is launching tomorrow. What makes this particular mission different from other ISS rotations?
Mimi
Most of what happens on the station is maintenance and incremental science. Menon's eight months are almost entirely devoted to research that NASA needs answered before it sends people to the Moon or Mars. The work is foundational.
Luke
But we should be clear about the timeline. He's launching in 2026, returning in 2027. These findings won't inform lunar missions for years. This is long-term groundwork.
Mark
What's the most urgent question his research is trying to answer?
Mimi
How does the human body actually break down in microgravity, and can we fix it? Blood pooling, vein degradation, muscle loss—these aren't theoretical problems. They're real obstacles to long-duration spaceflight.
Luke
Right, but the blood circulation research has been ongoing for decades. What's new here is the IV fluid production technology and the AI-augmented ultrasound work. Those are the novel pieces.
Mark
Why does producing IV fluids in space matter so much?
Mimi
On a Mars mission, you can't resupply from Earth. If an astronaut gets dehydrated or needs fluids for any reason, you need to be able to make them from what you have. Water is heavy to launch, so if you can use the station's potable water system to produce IV fluids, you've solved a logistics problem.
Luke
Though we should note the source doesn't specify how far along that technology is. It's being tested. We don't know if it will work at scale.
Mark
What about the semiconductor crystal work? That seems less directly connected to astronaut health.
Mimi
It's not. It's about enabling the technology that will support deep-space missions—AI systems, advanced computing, medical devices. You're building the infrastructure for the future.
Luke
And his wife flew to space last year?
Mimi
Yes, on a private mission. So they're both astronauts, both in the program. That's unusual.
Mark
Does his background in emergency medicine give him an advantage for this work?
Mimi
Absolutely. He understands human physiology at a level most astronauts don't. He's trained to make decisions under pressure with incomplete information. That's exactly what you need when you're eight months from Earth.
Luke
Though we should note he's also a flight surgeon with NASA experience and helped build SpaceX's medical program. It's not just the emergency medicine background—it's the full arc of his career that prepared him for this.
Il Polso
- Every experiment Menon carries into orbit is driven by a single urgent problem: the human body was not designed for deep space, and NASA must solve that before it can send people to Mars.
- Microgravity quietly dismantles the circulatory system over months — Menon's blood-flow and vein-structure studies aim to map that damage before it becomes irreversible on a mission too far away to abort.
- A technology capable of producing IV fluids from the station's own water supply could be the difference between life and death on a mission where the next resupply ship is millions of kilometers away.
- AI-augmented ultrasound research is pushing toward a future where astronauts diagnose and treat themselves without waiting for a physician on Earth — because on a Mars mission, the communication delay alone could cost a life.
- Menon's eight-month mission lands as a critical data deposit in NASA's long account, one the agency will draw on when it finally commits crews to journeys from which there is no quick return.
On July 14, physician and Space Force colonel Anil Menon lifted off from the ancient steppe of Kazakhstan aboard a Russian Soyuz capsule, bound for eight months on the International Space Station. His mission is less about the journey itself than about what comes after — the Moon, Mars, and the profound medical unknowns that await human beings who venture that far from home. Born in Minneapolis to immigrant parents who crossed continents to build a life, Menon now crosses into orbit carrying questions whose answers may determine whether humanity can sustain itself beyond Earth's embrace.
On July 14, Anil Menon — emergency medicine physician, US Space Force colonel, and son of Indian and Ukrainian immigrants — launched from the Baikonur Cosmodrome aboard Russia's Soyuz MS-29, bound for the International Space Station. Traveling alongside cosmonauts Pyotr Dubrov and Anna Kikina, he will spend eight months in orbit conducting research NASA considers essential to the future of human spaceflight. The crew is scheduled to return in April 2027.
Menon's life has been shaped by a recurring instinct: to position himself where help is scarce and the stakes are total. He volunteered medical care to climbers on Everest, deployed to Afghanistan, and spent a year in India studying polio immunization. He joined NASA in 2014 as a flight surgeon, then moved to SpaceX, where he built the company's medical program and helped prepare crews for the first Dragon flights. NASA selected him as an astronaut candidate in December 2021. His wife, Anna Menon, flew to space herself in September 2024 aboard the Polaris Dawn mission.
His work aboard the station is almost entirely scientific. He will study how microgravity alters blood circulation, vein structure, and blood composition — mapping the physiological toll of long-duration spaceflight. He will test technology that produces intravenous fluids from the station's potable water, a potentially lifesaving capability on missions where resupply is impossible. He will also work on manufacturing semiconductor crystals in microgravity, supporting the development of AI and advanced medical hardware.
Perhaps the most consequential thread of his research involves AI-augmented ultrasound — developing techniques that could allow astronauts to diagnose and treat themselves autonomously, without real-time guidance from Earth. On a Mars mission, where communication delays can stretch to twenty minutes each way, that independence is not a convenience. It is a survival requirement. Everything Menon does over the next eight months is, in that sense, a rehearsal for a journey humanity has not yet made.
On July 14, an emergency medicine physician and US Space Force colonel named Anil Menon will strap into a Russian Soyuz capsule at the Baikonur Cosmodrome in Kazakhstan and launch toward the International Space Station. He will spend the next eight months in orbit conducting research that NASA believes will be essential to keeping astronauts alive during the longer, deeper missions the agency is planning—journeys to the Moon and Mars that will push the human body into environments we have barely tested.
Menon, born in Minneapolis to Indian and Ukrainian immigrant parents, has spent his career moving between worlds. He trained as an emergency medicine doctor, then served as a colonel in the US Space Force, following an earlier tour in the Air Force that included deployment to Afghanistan. At one point, he volunteered with the Himalayan Rescue Association, providing medical care to climbers on Mount Everest—work that seems almost quaint compared to what he is about to do, though it speaks to a pattern: he has spent his professional life preparing for situations where help is far away and the stakes are absolute. He also spent a year in India as a Rotary Ambassadorial Scholar studying polio immunization programs, maintaining ties to his family's country of origin even as his career unfolded in the United States.
His path to this launch has been methodical. In 2014, Menon joined NASA as a flight surgeon, monitoring the health of astronauts aboard the station. Four years later, he moved to SpaceX, where he built the company's medical program from the ground up and helped prepare crews for the first crewed flights of SpaceX's Dragon capsule. He also contributed to the development of Starship, the next-generation spacecraft designed for lunar and Martian missions. In December 2021, NASA selected him as an astronaut candidate. He completed the agency's two-year training program and is now ready to fly. His wife, Anna Menon, is also an astronaut; she flew to space in September 2024 aboard SpaceX's Polaris Dawn mission, a privately funded flight that lasted about five days.
When Menon reaches the station, he will not be there to conduct routine maintenance or repairs. His mission is almost entirely scientific, focused on questions that will determine whether humans can survive and work effectively in the deep-space environment NASA is preparing to enter. He will study how microgravity changes blood circulation, the structure of veins, and blood composition itself—work aimed at understanding and eventually preventing the physiological damage that long-duration spaceflight inflicts on the human body. He will test new technology capable of producing intravenous fluids using the station's potable water system, a capability that could prove critical on missions where resupply is impossible and medical emergencies cannot be deferred to Earth.
Two other research areas will occupy significant portions of his time. One involves manufacturing semiconductor crystals in the microgravity environment, work intended to support the production of high-quality components for artificial intelligence systems and advanced medical technologies. The other is perhaps the most forward-looking: he will conduct ultrasound studies using augmented reality and artificial intelligence, developing medical techniques that could allow astronauts to diagnose and treat themselves during deep-space missions, reducing their dependence on real-time guidance from physicians on Earth.
Menon will launch at 10:47 am EDT on July 14 aboard Soyuz MS-29, traveling with Russian cosmonauts Pyotr Dubrov and Anna Kikina. The spacecraft will complete two orbits around Earth before docking with the station, where the crew will participate in Expeditions 74 and 75. They are scheduled to return to Earth in April 2027. The mission represents not just a personal milestone for Menon, but a crucial data-gathering exercise for an agency that is betting its future on the ability to send humans farther from home than ever before—and to keep them alive when they get there.
Citazioni salienti
Menon will carry out a series of scientific investigations aimed at improving understanding of how long-duration spaceflight affects the human body.— NASA mission briefing (paraphrased)
Vuoi la storia completa?
Leggi l'originale su Moneycontrol ↗
Science & Space